Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy with FOLFOX: Improved outcomes in Chinese patients with locally advanced gastric cancer

Published:2011-12-20 Issue:8 Volume:105 Page:793-799
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Li Zi-Yu,Koh Cherry E.,Bu Zhao-De,Wu Ai-Wen,Zhang Lian-Hai,Wu Xiao-Jiang,Wu Qi,Zong Xiang-Long,Ren Hui,Tang Lei,Zhang Xiao-Peng,Li Ji-You,Hu Ying,Shen Lin,Ji Jia-Fu

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference49 articles.

1. Global cancer statistics;Parkin;CA Cancer J Clin,2005

2. Gastric cancer: Epidemiology, pathology and treatment;Alberts;Ann Oncol,2003

3. Incidence and mortality of gastric cancer in China;Yang;World J Gastroenterol,2006

4. East meets west in the treatment of gastric cancer;Cunningham;N Eng J Med,2007

5. Nyren O survival in stomach cancer is improving: Results of a nationwide population-based Swedish study;Hansson;Ann Surg,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer;Frontiers in Oncology;2024-09-05

2. Neoadjuvant therapy with immune checkpoint inhibitors in combination with chemotherapy vs. chemotherapy alone in HER2(–) locally advanced gastric cancer: A propensity score-matched cohort study;Chinese Medical Journal;2024-02-29

3. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer;World Journal of Gastrointestinal Surgery;2024-02-27

4. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023;Cancer Communications;2023-12-31

5. ApoA-I and ApoB levels, and ApoB-to-ApoA-I ratio as candidate pre-treatment biomarkers of pathomorphological response to neoadjuvant therapy in gastric and esophago-gastric junction adenocarcinoma;Polish Journal of Surgery;2023-09-20